Lina M Felipez
Overview
Explore the profile of Lina M Felipez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
18
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rios Melendez S, Majluta A, Medina A, Restrepo R, Felipez L
J Pediatr Gastroenterol Nutr
. 2024 Feb;
78(2):289-294.
PMID: 38374559
Vulvar involvement as an extraintestinal manifestation of Crohn's disease (CD) is a challenging diagnosis considering that vaginal findings may precede gastrointestinal symptoms. The aim of this study is to describe...
2.
Sunny J, Fonseca A, Crim A, Goyal A, Felipez L
JPGN Rep
. 2023 May;
3(2):e205.
PMID: 37168900
Ustekinumab (UST) is a human IgG1K monoclonal antibody that binds to the p40 receptor subunit bound by cytokines IL-12 and IL-23. It is indicated in both Crohn's disease and ulcerative...
3.
Fonseca A, Sunny J, Felipez L
Case Rep Pediatr
. 2021 Aug;
2021:9989729.
PMID: 34336341
Crohn's disease (CD) is a chronic inflammatory disease that can be associated with intestinal and extraintestinal manifestations. Some patients are treated with infliximab, an antitumor necrosis factor-alpha (TNF-) agent, to...
4.
Fonseca A, Sunny J, Felipez L
Case Rep Pediatr
. 2021 Jun;
2021:1996430.
PMID: 34104503
Inflammatory bowel disease (IBD) that presents in children <6 years of age is known as very early-onset IBD (VEO-IBD). Extraintestinal manifestations in IBD, such as erythema nodosum (EN), pyoderma gangrenosum...
5.
Felipez L, Gokhale R, Tierney M, Kirschner B
J Pediatr Gastroenterol Nutr
. 2011 Jun;
54(1):28-33.
PMID: 21681114
Objective: The aim of the study was to evaluate thalidomide as rescue therapy for pediatric patients with severe refractory Crohn disease (CD) who failed to respond to antitumor necrosis factor...